Propanc Biopharma Ord Shs
PPCB0.215USD
-0.014-6.03%
Market hours （ET）Quotes delayed by 15 min
2.87MMarket Cap
0.01P/E TTM
More Details of Company
Propanc Biopharma Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Propanc Biopharma Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Julian Norman Kenyon
Dr. Julian Norman Kenyon
Director
Director
2.50M
--
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
2.00M
--
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
50.00K
--
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
--
--
Ms. Jeannine Zimmerman
Ms. Jeannine Zimmerman
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Annie Vanbroekhoven
Ms. Annie Vanbroekhoven
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Julian Norman Kenyon
Dr. Julian Norman Kenyon
Director
Director
2.50M
--
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
2.00M
--
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
50.00K
--
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
--
--
Ms. Jeannine Zimmerman
Ms. Jeannine Zimmerman
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Annie Vanbroekhoven
Ms. Annie Vanbroekhoven
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Nathanielsz (Sylvia)
28.43%
Kenyon (Julian Norman)
18.71%
Zelinger (Josef)
14.96%
Marex Group plc
0.53%
Himy (Joseph)
0.37%
Other
36.99%
Shareholders
Shareholders
Proportion
Nathanielsz (Sylvia)
28.43%
Kenyon (Julian Norman)
18.71%
Zelinger (Josef)
14.96%
Marex Group plc
0.53%
Himy (Joseph)
0.37%
Other
36.99%
Shareholder Types
Shareholders
Proportion
Individual Investor
62.48%
Investment Advisor
0.53%
Research Firm
0.31%
Other
36.68%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
4
112.11K
9.41%
--
2025Q4
4
112.11K
0.84%
-1.15M
2025Q3
4
112.11K
0.84%
-1.15M
2025Q2
1
900.01K
7.75%
+900.01K
2022Q4
1
--
0.00%
--
2022Q3
2
--
0.00%
--
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Nathanielsz (Sylvia)
3.80M
28.43%
--
--
Dec 15, 2025
Kenyon (Julian Norman)
2.50M
18.71%
--
--
Dec 15, 2025
Zelinger (Josef)
2.00M
14.96%
--
--
Dec 15, 2025
Marex Group plc
70.43K
0.53%
+70.43K
--
Sep 30, 2025
Himy (Joseph)
50.00K
0.37%
--
--
Dec 15, 2025
Virtu Americas LLC
41.68K
0.31%
+41.68K
--
Sep 30, 2025
Morgan Stanley Smith Barney LLC
1.00
0%
+1.00
--
Sep 30, 2025
Ionic Ventures LLC
--
0%
-1.26M
-100.00%
Sep 30, 2025
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
